Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen Sodium and Aspirin Interaction Study
NCT02229461Phase 1Completed
- Sponsor
- Bayer
- Start
- Feb 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Aprol in pain (6 arms), sponsored by Bayer. Primary endpoint: Inhibition of Serum Thromboxane B2 (TXB2) at Day 16. Started Feb 2015; status: completed.
02
Drugs
Aprol
03
Conditions
pain
Beyond the preview
Go deeper on NCT02229461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229461.